(Q71949047)

English

Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: Comparison with CA 125 and the aminoterminal propeptide of type III procollagen

scientific article published on 01 July 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: Comparison with CA 125 and the aminoterminal propeptide of type III procollagen (English)

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

1 reference

based on heuristic

inferred from title

endometrial adenocarcinoma

1 reference

based on heuristic

inferred from title

N-Terminal Propeptide of Type III Collagen

1 reference

based on heuristic

inferred from title

author name string

A. Hakala

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

B. M. Kacinski

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

E. R. Stanley

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

E. I. Kohorn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

U. Puistola

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

J. Risteli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

L. Risteli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

C. Tomás

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

A. Kauppila

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

language of work or name

1 reference

American Journal of Obstetrics and Gynecology

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

full work available at URL

https://doi.org/10.1016/0002-9378(95)90178-7

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7631667

23 June 2024

https://api.elsevier.com/content/article/PII:0002937895901787?httpAccept=text/xml

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

https://api.elsevier.com/content/article/PII:0002937895901787?httpAccept=text/plain

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

173

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

112-119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Pros and cons of gynecologic tumor markers

1

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

The CA 125 tumour-associated antigen: a review of the literature

2

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

CA 125: a useful marker in endometrial carcinoma

4

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinoma

5

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Aminoterminal propeptide of type III procollagen in ovarian cancer. A review

6

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas.

7

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients.

8

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

CSF-1--a mononuclear phagocyte lineage-specific hemopoietic growth factor

9

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Expression of colony-stimulating factor-1 in the human uterus and placenta

11

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Reporting results of cancer treatment

13

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

CA 125 in gynecological pathology--a review

14

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

CA 125 in the follow-up of patients with ovarian cancer

15

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms

16

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

19

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies

20

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines

23

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1

24

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1

25

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?

26

1 reference

10.1016/0002-9378(95)90178-7

https://api.crossref.org/works/10.1016/0002-9378(95)90178-7

23 June 2024

Identifiers

10.1016/0002-9378(95)90178-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7631667%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71949047&oldid=2187248415"